Strides Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
1,107.65
0.55 (0.05%)
BSENSE

Jun 18

BSE+NSE Vol: 1.28 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,107.65",
    "chg": 0.55,
    "chgp": "0.05%",
    "dir": 1,
    "prev_price": "1,107.10",
    "mcapval": "10,209.51 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.28 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Strides Pharma Q4FY26 results: Net profit jumps 51% to 129 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-18 16:14:09",
        "description": "Strides Pharma Q4FY26 results: Net profit jumps 51% to 129 crore  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "688428",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Jun-2026",
      "details": "Intimation of Schedule of Analyst/ Institutional Investors Meet",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited (Arco Lab) And Pivot Path Private Limited (Pivot Path)",
      "datetime": "01-Jun-2026",
      "details": "Intimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited (Arco Lab) and (Pivot Path Private Limited).",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF",
      "datetime": "01-Jun-2026",
      "details": "Reminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25",
          "dt": "2025-07-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Jun-2026 | Source : BSE

Intimation of Schedule of Analyst/ Institutional Investors Meet

Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited (Arco Lab) And Pivot Path Private Limited (Pivot Path)

01-Jun-2026 | Source : BSE

Intimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited (Arco Lab) and (Pivot Path Private Limited).

Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF

01-Jun-2026 | Source : BSE

Reminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Strides Pharma Science Ltd has declared 40% dividend, ex-date: 22 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available